| 中文名稱:布瓦西坦雜質(zhì) | 英文名稱:Brivaracetam Impurity |
| 純度規(guī)格: 95%+ | 產(chǎn)品類別: 雜質(zhì)對照品標準品 |
|
產(chǎn)品名稱 |
CAS號 |
分子式分子量 |
規(guī)格 |
|
布瓦西坦(alfaR, 4R)異構(gòu)體雜質(zhì) Brivaracetam (alfaR, 4R)-Isomer |
357337-00-9 |
C11H20N2O2 M.W. 212.29
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦(αS, 4S)異構(gòu)體雜質(zhì) Brivaracetam (αS, 4S)-Isomer |
357336-19-7 |
C11H20N2O2 M.W. 212.29
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
Brivaracetam (alfaR, 4S)-Isomer |
357336-99-3 |
C11H20N2O2 M.W. 212.29
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
消旋布瓦西坦雜質(zhì) rac-Brivaracetam (Mixture of Diastereomers)
|
357335-87-6 |
C11H20N2O2 M.W. 212.29
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)1 Brivaracetam Impurity 1
|
112106-16-8 |
C11H20O4 M.W. 216.28
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)2 Brivaracetam Impurity 2
|
1928755-17-2 |
C11H22O3 M.W. 202.29
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)3 Brivaracetam Impurity 3
|
NA |
C11H20O4 M.W. 216.28
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)4 Brivaracetam Impurity 4
|
63095-51-2 |
C7H12O2 M.W. 128.17
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)5 Brivaracetam Impurity 5 |
1942054-60-5 |
C7H13BrO2 M.W. 209.08
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)6 Brivaracetam Impurity 6 |
1956435-91-8 |
C9H17BrO2 M.W. 237.14
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)7 Brivaracetam Impurity 7 |
748760-80-7 |
C13H26N2O3 M.W. 258.36
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)8 Brivaracetam Impurity 8 |
943986-67-2 |
C11H19NO3 M.W. 213.28
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)9 Brivaracetam Impurity 9 |
NA |
C15H27N3O3 M.W. 297.40
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)10 Brivaracetam Impurity 10 |
60559-16-2 |
C10H20O2 M.W. 172.27
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)11 Brivaracetam Impurity 11 |
NA |
C12H24N2O3 M.W. 244.34
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)12 Brivaracetam Impurity 12 |
NA |
C11H20N2O2 M.W. 212.29
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)13 Brivaracetam Impurity 13 |
NA |
C11H20N2O3 M.W. 228.147
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)14 Brivaracetam Impurity 14 |
NA |
C11H20N2O3 M.W. 228.147
|
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)15 (Z)-3-((E)-(((S)-1-amino-1-oxobutan-2-yl)imino)methyl)hex-2-enoic acid |
NA |
C11H18N2O3 226.28 |
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)16 (S,Z)-N-(1-amino-1-oxobutan-2-yl)-3-formylhex-2-enamide |
NA |
C11H18N2O3 226.28 |
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)17 (S)-2-((S)-2-oxo-4-propylpyrrolidin-1-yl)butanoic acid |
NA |
C11H19NO3 213.28 |
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)18 isopropyl (S)-2-((S)-2-oxo-4-propylpyrrolidin-1-yl)butanoate |
NA |
C14H25NO3 255.36 |
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)19 isopropyl (S)-2-((R)-2-oxo-4-propylpyrrolidin-1-yl)butanoate |
NA |
C14H25NO3 255.36 |
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)20 (S)-3-((((S)-1-amino-1-oxobutan-2-yl)amino)methyl)hexanoic acid |
NA |
C10H20N2O3 216.28 |
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)21 (R,Z)-N-(1-amino-1-oxobutan-2-yl)-3-formylhex-2-enamide |
NA |
C11H18N2O3 226.28 |
10mg/25mg/50mg/100mg/200mg/500mg |
|
布瓦西坦雜質(zhì)22 isopropyl (R)-3-((((S)-1-amino-1-oxobutan-2-yl)amino)methyl)hexanoate maleate |
NA |
C14H28N2O3. C4H4O 272.39. 116.07 |
10mg/25mg/50mg/100mg/200mg/500mg |
| 成立日期 | 2016-09-06 (10年) | 注冊資本 | 100.000000萬人民幣 |
| 員工人數(shù) | 1-10人 | 年營業(yè)額 | ¥ 500萬-1000萬 |
| 主營行業(yè) | 化學試劑,醫(yī)藥原料 | 經(jīng)營模式 | 貿(mào)易,試劑,定制 |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| ¥480 |
VIP5年
|
深圳摩科生化科技有限公司
|
2026-06-11 | |
| 詢價 |
VIP3年
|
普善實業(yè)(陜西)有限公司
|
2026-06-10 | |
| 詢價 |
VIP3年
|
深圳市恒豐萬達醫(yī)藥科技有限公司
|
2026-05-22 | |
| 詢價 |
深圳市恒豐萬達醫(yī)藥科技有限公司
|
2023-05-27 | ||
| 詢價 |
深圳卓越生物科技有限公司
|
2021-05-12 |